Monte Rosa Therapeutics Stock Price Prediction
| GLUE Stock | USD 16.01 1.61 11.18% |
Momentum 49
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.14) | EPS Estimate Current Year (0.20) | EPS Estimate Next Year (1.32) | Wall Street Target Price 22.7 | EPS Estimate Current Quarter (0.35) |
Using Monte Rosa hype-based prediction, you can estimate the value of Monte Rosa Therapeutics from the perspective of Monte Rosa response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Monte Rosa using Monte Rosa's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Monte using crowd psychology based on the activity and movement of Monte Rosa's stock price.
Monte Rosa Short Interest
A significant increase or decrease in Monte Rosa's short interest from the previous month could be a good indicator of investor sentiment towards Monte. Short interest can provide insight into the potential direction of Monte Rosa stock and how bullish or bearish investors feel about the market overall.
200 Day MA 7.7624 | Short Percent 0.1401 | Short Ratio 8.95 | Shares Short Prior Month 7 M | 50 Day MA 14.9346 |
Monte Rosa Therapeutics Hype to Price Pattern
Investor biases related to Monte Rosa's public news can be used to forecast risks associated with an investment in Monte. The trend in average sentiment can be used to explain how an investor holding Monte can time the market purely based on public headlines and social activities around Monte Rosa Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Monte Rosa's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Monte Rosa.
Monte Rosa Implied Volatility | 1.55 |
Monte Rosa's implied volatility exposes the market's sentiment of Monte Rosa Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Monte Rosa's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Monte Rosa stock will not fluctuate a lot when Monte Rosa's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Monte Rosa to buy its stock at a price that has no basis in reality. In that case, they are not buying Monte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Monte Rosa after-hype prediction price | USD 16.52 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Monte contract
Based on the Rule 16, the options market is currently suggesting that Monte Rosa Therapeutics will have an average daily up or down price movement of about 0.0969% per day over the life of the 2026-04-17 option contract. With Monte Rosa trading at USD 16.01, that is roughly USD 0.0155 . If you think that the market is fully incorporating Monte Rosa's daily price movement you should consider acquiring Monte Rosa Therapeutics options at the current volatility level of 1.55%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Monte Rosa Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Monte Rosa's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Monte Rosa After-Hype Price Prediction Density Analysis
As far as predicting the price of Monte Rosa at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Monte Rosa or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Monte Rosa, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Monte Rosa Estimiated After-Hype Price Volatility
In the context of predicting Monte Rosa's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Monte Rosa's historical news coverage. Monte Rosa's after-hype downside and upside margins for the prediction period are 10.80 and 22.24, respectively. We have considered Monte Rosa's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Monte Rosa is somewhat reliable at this time. Analysis and calculation of next after-hype price of Monte Rosa Therapeutics is based on 3 months time horizon.
Monte Rosa Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Monte Rosa is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Monte Rosa backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Monte Rosa, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.21 | 5.72 | 0.51 | 0.13 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.01 | 16.52 | 3.19 |
|
Monte Rosa Hype Timeline
Monte Rosa Therapeutics is currently traded for 16.01. The entity has historical hype elasticity of 0.51, and average elasticity to hype of competition of 0.13. Monte is anticipated to increase in value after the next headline, with the price projected to jump to 16.52 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 3.19%, whereas the daily expected return is currently at 1.21%. The volatility of related hype on Monte Rosa is about 5345.79%, with the expected price after the next announcement by competition of 16.14. Monte Rosa Therapeutics currently holds 42.72 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out Monte Rosa Basic Forecasting Models to cross-verify your projections.Monte Rosa Related Hype Analysis
Having access to credible news sources related to Monte Rosa's direct competition is more important than ever and may enhance your ability to predict Monte Rosa's future price movements. Getting to know how Monte Rosa's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Monte Rosa may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DAWN | Day One Biopharmaceuticals | 0.17 | 3 per month | 3.84 | 0.05 | 9.09 | (7.32) | 39.62 | |
| ARVN | Arvinas | 0.17 | 10 per month | 3.23 | 0.07 | 5.48 | (4.42) | 28.90 | |
| REPL | Replimune Group | 0.07 | 8 per month | 2.81 | 0.10 | 6.02 | (5.07) | 108.39 | |
| TBPH | Theravance Biopharma | 0.14 | 10 per month | 2.04 | 0.10 | 3.74 | (3.58) | 28.70 | |
| AVBP | ArriVent BioPharma Common | (0.17) | 3 per month | 3.26 | (0.01) | 6.31 | (5.62) | 16.37 | |
| GERN | Geron | 0.12 | 11 per month | 0.00 | (0.04) | 6.98 | (5.19) | 15.67 | |
| VIR | Vir Biotechnology | 0.01 | 6 per month | 3.76 | 0.02 | 7.75 | (6.04) | 16.61 | |
| DNA | Ginkgo Bioworks Holdings | 0.12 | 10 per month | 0.00 | (0.15) | 8.16 | (9.38) | 33.15 | |
| VALN | Valneva SE ADR | (0.18) | 5 per month | 0.00 | (0.10) | 4.83 | (3.36) | 14.16 | |
| MGTX | MeiraGTx Holdings PLC | 0.62 | 8 per month | 0.00 | (0.05) | 6.05 | (5.54) | 18.08 |
Monte Rosa Additional Predictive Modules
Most predictive techniques to examine Monte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Monte using various technical indicators. When you analyze Monte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Monte Rosa Predictive Indicators
The successful prediction of Monte Rosa stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Monte Rosa Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Monte Rosa based on analysis of Monte Rosa hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Monte Rosa's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Monte Rosa's related companies. | 2025 | 2026 (projected) | Interest Debt Per Share | 0.52 | 0.66 | Revenue Per Share | 0.92 | 0.82 |
Story Coverage note for Monte Rosa
The number of cover stories for Monte Rosa depends on current market conditions and Monte Rosa's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Monte Rosa is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Monte Rosa's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Monte Rosa Short Properties
Monte Rosa's future price predictability will typically decrease when Monte Rosa's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Monte Rosa Therapeutics often depends not only on the future outlook of the potential Monte Rosa's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Monte Rosa's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.9 M | |
| Cash And Short Term Investments | 372.1 M |
Complementary Tools for Monte Stock analysis
When running Monte Rosa's price analysis, check to measure Monte Rosa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monte Rosa is operating at the current time. Most of Monte Rosa's value examination focuses on studying past and present price action to predict the probability of Monte Rosa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monte Rosa's price. Additionally, you may evaluate how the addition of Monte Rosa to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |